Author: OurCrowd

[Biolojic in Haaretz] From Israeli Lab: First AI-designed Antibody Enters Clinical Trials

Aulos Biosciences is now recruiting cancer patients in Australian medical centers for a trial of the world’s first antibody drug designed by a computer. The computationally designed antibody, known as AU-007, was planned by the artificial intelligence platform of Israeli biotech company Biolojic Design from Rehovot, in a way that would target a protein in the human body known as interleukin-2 (IL-2). Read...

Read More